| Unique ID issued by UMIN | UMIN000009329 |
|---|---|
| Receipt number | R000010811 |
| Scientific Title | Study of Clinical Usefulness of 18F-fluorothymidine(FLT) PET/CT in Ditection of Peritoneal Metastases of Gastric Cancer |
| Date of disclosure of the study information | 2012/11/13 |
| Last modified on | 2015/05/13 09:18:47 |
Study of Clinical Usefulness of 18F-fluorothymidine(FLT) PET/CT in Ditection of Peritoneal Metastases of
Gastric Cancer
Study of Usefulness of 18F-FLT PET/CT in Peritoneal Metastases of Gastric Cancer
Study of Clinical Usefulness of 18F-fluorothymidine(FLT) PET/CT in Ditection of Peritoneal Metastases of
Gastric Cancer
Study of Usefulness of 18F-FLT PET/CT in Peritoneal Metastases of Gastric Cancer
| Japan |
Gastric cancer patients with peritoneal
metastases
| Radiology |
Malignancy
NO
To confirm usefulness of 18F-FLT PET/CT in the diagnosis of peritoneal metastases of gastric cancer.
Efficacy
Confirmatory
Pragmatic
Phase II
Sensitivity of 18F-FLT PET/CT in the diagnosis of peritoneal metastases of gastric cancer.
Safety of 18F-FLT
Sensitivity of 18F-FLT PET/CT in the diagnosis of primary or metastatic lesion of gastric cancer.
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Diagnosis
| Medicine |
Injection of 2-8 MBq/kg 18F-FLT,
PET/CT imaging study of one hour, and
blood examinations after one week of
inspections.
| 20 | years-old | <= |
| Not applicable |
Male and Female
[A-part]
1.Equal to or over 20 years.
2.Established diagnosis of gastric cancer
by histology or cytology.
3.Rough peritoneal metastases are
detected by diagnostic imaing performed
within 4 weeks.
4.Performance status:0-2.
5.Main organs functions must be normal.
6.Written informed concent can be
obtained.
[B-part]
1.Equal to or over 20 years.
2.Established diagnosis of gastric cancer
by histology or cytology.
3.Peritoneal metastases are detected by
diagnostic laparoscopy or surgical
finding performed within 4 weeks.
4.Performance status:0-2.
5.Main organs functions must be normal.
6.Written informed concent can be
1.Peritoneal metastases detected
only by cytology of ascites.
2.Patients who have alcoholic hyper-
sensitivity.
3.Patients with active infection.
4.Pregnant women or women who have the
possibility to be pregnant or lactating
woman.
5.Patients who are considered to be
ineligible by referring physician.
40
| 1st name | |
| Middle name | |
| Last name | Yasuhide Yamada |
National Cancer Center Hospital in Japan
Department of Gastrointestinal Oncology
Tsukiji 5-1-1, Chuo-ku, Tokyo
03-3542-2511
yayamada@ncc.go.jp
| 1st name | |
| Middle name | |
| Last name | Yoshitaka Honma |
National Cancer Center Hospital in Japan
Department of Gastrointestinal Oncology
Tsukiji 5-1-1, Chuo-ku, Tokyo
03-3542-2511
yohonma@ncc.go.jp
Department of Gastrointestinal Oncology,
National Cancer Center Hospital in Japan
Department of Gastrointestinal Oncology,
National Cancer Center Hospital in Japan
Other
YES
2012-039
IRB of National Cancer Center Hospital in Japan
国立がん研究センター中央病院(東京都)
National Cancer Center Hospital(Tokyo)
| 2012 | Year | 11 | Month | 13 | Day |
Unpublished
Completed
| 2012 | Year | 07 | Month | 19 | Day |
| 2012 | Year | 08 | Month | 08 | Day |
| 2015 | Year | 05 | Month | 01 | Day |
| 2015 | Year | 05 | Month | 01 | Day |
| 2015 | Year | 05 | Month | 01 | Day |
| 2015 | Year | 05 | Month | 01 | Day |
| 2012 | Year | 11 | Month | 13 | Day |
| 2015 | Year | 05 | Month | 13 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000010811